Tongyao Group (the “Group”) is an integrated pharmaceutical enterprise. The Group is located in the first Pharmaceutical Industrial Park of Datong Shanxi province. The average temperature is 7-9℃ and annual average precipitation is 50mm, which provide the right condition for pharmacy. The plant area is 250,000 m². Applying advanced modernized Chinese and biomedical technology, the Group researches, develops, manufactures and markets a vast array of health enhancing modernized Chinese medicines, chemical medicines and biopharmaceutical products.
The Group’s principle subsidiaries: Shanxi Tongda Pharmaceutical Co. (“Tongda”), Ltd, Tongyao Group Datong Pharmaceutical Co. (“Datong”), Ltd, Weiqida Guangming Pharmaceutical Co. (“Guangming”), Shanxi Fuyuan Pharmaceutical Co. (“Fuyuan”) and Linzhitang chain drugstores (“Linzhitang”). Tongda and Guangming have been designated “High and New Technology Enterprises”. Fuyuan is the largest distributor for pharmaceutical products and medical instruments of Shanxi province.
The medicines which have received Good Manufacturing Practice (“GMP”) certifications issued by the State Food and Drug Administration of the PRC are in the following dosage forms: small volume injections, PVC-free soft bags for intravenous injections, capsules, tablets, powdered medicines, granulated medicines and traditional Chinese medicines prepared in ready-to-use forms.
The Group has built 12 production shop including penicillin injection, cephalosporin, common oral preparation, raw materials drug, extraction of Chinese herbal medicine, solid Chinese medicine, biologics, lyophilized powder for injection, small volume injection, health products, traditional Chinese medicines prepared in ready-to-use forms and medical instruments, and 30 production lines such as injection, capsules and tablets. The production capacity is 6,000 million for tablets, 1,500 million for capsules, 500 million for granulated medicines, 100 million for suppositories, 100 million for small volume injections, 50 million for lyophilized powder for injection, 15 million for biologics, 1,000 million for Chinese medicine, 600 tons for extraction of Chinese herbal medicine and 100 tons for raw materials drug.
The Group’s sales consists of three parts. The sales center is responsible for the marketing of the manufactured drugs. The Group established 20 sales offices across China to promote the products. Fuyuan mainly engage in wholesale and distribution of drugs and medical instruments, and has business relationship with over 4,000 companies. The sales revenue is over 1,000 million in 2015. Linzhitang is retail store chain and has 84 shops that locate in Datong and surrounding areas. The sales revenue is around 100 million in 2015.
The Group has been consistently value the quality first. With its commitment to innovation for good health and creating a better future, Tongyao Group remains on its mission to promote health and well-being. In order to enhance our sustainable competitiveness, the Group also actively seeks for cooperation with the international enterprises, promote the enlarged healthcare industry strategy.
字体大小：T T T